Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$520,808,395
+$1,130,935 QoQ
Shares Held
2,746,590
+4.2% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#55
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $5,124,714,999 across 15 Drug Manufacturers - General names. AZN ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,697,061 | $2,035,506,044 | |
| 2 | JNJ |
Johnson & Johnson
|
4,126,113 | $1,047,908,917 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
2,746,590 | $520,808,395 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,533,955 | $454,113,217 | |
| 5 | ABBV |
AbbVie Inc.
|
1,279,175 | $321,891,596 | |
| 6 | PFE |
Pfizer Inc
|
10,281,652 | $247,582,179 | |
| 7 | AMGN |
Amgen Inc
|
646,798 | $234,218,491 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,361,825 | $172,052,970 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $520,808,395 | 2,746,590 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $519,677,460 | 2,635,014 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||